Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Rhoen-Klinikum AG    RHK   DE0007042301

RHOEN-KLINIKUM AG

 (RHK)

12
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Rhoen-Klinikum AG : Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201020112012201320142015
Sales2 5512 6292 8653 0333 1453 268
Operating income (EBITDA)307355291330375408
Operating profit (EBIT)198213150182223254
Pre-Tax Profit (EBT)174186114148187227
Net income14515689,7113148178
EPS ( €)1,011,130,650,811,071,32
Dividend per Share ( €)0,370,450,250,340,420,50
Yield2,11%2,57%1,43%1,94%2,39%2,86%
Announcement Date02/10/2011
04:18pm
02/09/2012
09:13am
02/21/2013
06:29am
---
Finances - Leverage
Rhoen-Klinikum AG : Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201020112012201320142015
Debt552552802759687633
Finance------
Operating income (EBITDA)307355291330375408
Leverage
(Debt/EBITDA)
1,79x1,56x2,75x2,30x1,83x1,55x
Capital Expenditure348271274200187185
Book Value Per Share (BVPS)10,6 €11,3 €11,4 €12,1 €12,8 €13,6 €
Cash Flow per Share1,60 €2,20 €1,68 €1,99 €2,22 €2,47 €
Announcement Date02/10/2011
04:18pm
02/09/2012
09:13am
02/21/2013
06:29am
---
Balance Sheet Analysis
Rhoen-Klinikum AG : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 2 423 M€ -
Company Value 3 182 M€ 3 111 M€
Valuation 2013e 2014e
PER (Price / EPS) 21,6x 16,4x
Capitalization / Revenue 0,80x 0,77x
EV / Revenue 1,05x 0,99x
EV / EBITDA 9,65x 8,29x
Yield (DPS / Price) 1,94% 2,39%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 6,00% 7,10%
operating laverage (Delta EBIT / Delta Sales) 3,59x 6,15x
Net Margin (Net Profit / Revenue) 3,74% 4,70%
ROA (Net Profit / Asset) 3,50% 4,50%
ROE (Net Profit / Equities) 6,97% 8,78%
Rate of Dividend 41,8% 39,2%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   6,60% 5,94%
Cash Flow / Sales (Taux d'autofinancement) 9,06% 9,74%
Capital Intensity (Assets / Sales) 1,07x 1,05x
Financial Leverage (Net Debt / EBITDA) 2,30x 1,83x
Price Earning Ratio
Rhoen-Klinikum AG : Price Earning Ratio
EPS & Dividend
Rhoen-Klinikum AG : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.